153 related articles for article (PubMed ID: 19026485)
1. Cancer stem cell marker expression in hepatocellular carcinoma and liver metastases is not sufficient as single prognostic parameter.
Salnikov AV; Kusumawidjaja G; Rausch V; Bruns H; Gross W; Khamidjanov A; Ryschich E; Gebhard MM; Moldenhauer G; Büchler MW; Schemmer P; Herr I
Cancer Lett; 2009 Mar; 275(2):185-93. PubMed ID: 19026485
[TBL] [Abstract][Full Text] [Related]
2. Stem-like cells in hepatitis B virus-associated cirrhotic livers and adjacent tissue to hepatocellular carcinomas possess the capacity of tumorigenicity.
Sun YL; Yin SY; Xie HY; Zhou L; Xue F; Wu LM; Gao F; Zheng SS
J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1280-6. PubMed ID: 18466286
[TBL] [Abstract][Full Text] [Related]
3. KL-6 mucin in metastatic liver cancer tissues from primary colorectal carcinoma.
Zhang K; Tang W; Qu X; Guo Q; Inagaki Y; Seyama Y; Abe H; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
Hepatogastroenterology; 2009; 56(93):960-3. PubMed ID: 19760920
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma.
Gao Q; Wang XY; Qiu SJ; Yamato I; Sho M; Nakajima Y; Zhou J; Li BZ; Shi YH; Xiao YS; Xu Y; Fan J
Clin Cancer Res; 2009 Feb; 15(3):971-9. PubMed ID: 19188168
[TBL] [Abstract][Full Text] [Related]
5. Participation of liver cancer stem/progenitor cells in tumorigenesis of scirrhous hepatocellular carcinoma--human and cell culture study.
Fujii T; Zen Y; Harada K; Niwa H; Masuda S; Kaizaki Y; Watanabe K; Kawashima A; Nakanuma Y
Hum Pathol; 2008 Aug; 39(8):1185-96. PubMed ID: 18547618
[TBL] [Abstract][Full Text] [Related]
6. Liver cancer stem cells: implications for a new therapeutic target.
Lee TK; Castilho A; Ma S; Ng IO
Liver Int; 2009 Aug; 29(7):955-65. PubMed ID: 19490415
[TBL] [Abstract][Full Text] [Related]
7. The power and the promise of liver cancer stem cell markers.
Liu LL; Fu D; Ma Y; Shen XZ
Stem Cells Dev; 2011 Dec; 20(12):2023-30. PubMed ID: 21651381
[TBL] [Abstract][Full Text] [Related]
8. Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.
Ke Q; Ji J; Cheng C; Zhang Y; Lu M; Wang Y; Zhang L; Li P; Cui X; Chen L; He S; Shen A
Exp Mol Pathol; 2009 Dec; 87(3):167-72. PubMed ID: 19686732
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells in hepatocellular carcinoma: Recent progress and perspective.
Chiba T; Kamiya A; Yokosuka O; Iwama A
Cancer Lett; 2009 Dec; 286(2):145-53. PubMed ID: 19464789
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM.
Tsuchiya A; Kamimura H; Tamura Y; Takamura M; Yamagiwa S; Suda T; Nomoto M; Aoyagi Y
Cancer Lett; 2011 Oct; 309(1):95-103. PubMed ID: 21669487
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
12. CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.
Yang XR; Xu Y; Yu B; Zhou J; Li JC; Qiu SJ; Shi YH; Wang XY; Dai Z; Shi GM; Wu B; Wu LM; Yang GH; Zhang BH; Qin WX; Fan J
Clin Cancer Res; 2009 Sep; 15(17):5518-27. PubMed ID: 19706825
[TBL] [Abstract][Full Text] [Related]
13. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers.
Tanei T; Morimoto K; Shimazu K; Kim SJ; Tanji Y; Taguchi T; Tamaki Y; Noguchi S
Clin Cancer Res; 2009 Jun; 15(12):4234-41. PubMed ID: 19509181
[TBL] [Abstract][Full Text] [Related]
14. MACC 1 as a marker for vascular invasive hepatocellular carcinoma.
Shirahata A; Fan W; Sakuraba K; Yokomizo K; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Anticancer Res; 2011 Mar; 31(3):777-80. PubMed ID: 21498695
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary research of hepatocarcinoma stem cell markers].
Yan Z; Fang CH; Gao P
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1304-6. PubMed ID: 16982441
[TBL] [Abstract][Full Text] [Related]
16. Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis.
Umeda Y; Iwagaki H; Ozaki M; Ogino T; Iwamoto T; Yoshida R; Shinoura S; Matsuda H; Sadamori H; Tanaka N; Yagi T
Hepatogastroenterology; 2009; 56(93):971-7. PubMed ID: 19760923
[TBL] [Abstract][Full Text] [Related]
17. Expression of E- and N-cadherin and clinicopathology in hepatocellular carcinoma.
Cho SB; Lee KH; Lee JH; Park SY; Lee WS; Park CH; Kim HS; Choi SK; Rew JS
Pathol Int; 2008 Oct; 58(10):635-42. PubMed ID: 18801083
[TBL] [Abstract][Full Text] [Related]
18. Significance of CD90+ cancer stem cells in human liver cancer.
Yang ZF; Ho DW; Ng MN; Lau CK; Yu WC; Ngai P; Chu PW; Lam CT; Poon RT; Fan ST
Cancer Cell; 2008 Feb; 13(2):153-66. PubMed ID: 18242515
[TBL] [Abstract][Full Text] [Related]
19. Impact of portal vein embolization on expression of cancer stem cell markers in regenerated liver and colorectal liver metastases.
Williamson JM; Thairu N; Katsoulas N; Stamp G; Ahmad R; du Potet E; Levicar N; Gordon M; Stebbing J; Habib NA; Jiao LR
Scand J Gastroenterol; 2010 Dec; 45(12):1472-9. PubMed ID: 20586536
[TBL] [Abstract][Full Text] [Related]
20. Expression of cancer stem cell markers in metastatic colorectal cancer correlates with liver metastasis, but not with metastasis to the central nervous system.
Michl M; Heinemann V; Jung A; Engel J; Kirchner T; Neumann J
Pathol Res Pract; 2015 Aug; 211(8):601-9. PubMed ID: 26092596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
